Depo-Provera self-injection: checklist before your first dose

Depo-SubQ Provera 104 is the only formulation of medroxyprogesterone acetate designed for subcutaneous self-injection at home, and the prep work before that first dose is what separates reliable pregnancy prevention from a gap you didn't mean to open. This guide walks through everything you need to confirm, store, time, and physically do before the needle goes in — and what to plan around for the long haul.

Understanding the Subcutaneous Formulation: Why It Differs from IM

Depo-Provera has been around since 1959, when medroxyprogesterone acetate first received FDA approval, but the home-administered version you may be holding is a more recent arrival. Depo-SubQ Provera 104 contains 104 mg of medroxyprogesterone acetate in a prefilled syringe, formulated for subcutaneous injection into the anterior thigh or abdomen. The traditional clinic-administered version, often called "Depo-Provera CI" or simply "the shot," is an intramuscular (IM) injection of 150 mg given into the gluteal or deltoid muscle by a provider.

The difference matters in three practical ways. First, the subcutaneous version delivers 30% less progestin per dose (104 mg versus 150 mg) — the same contraceptive effect through a different route and a smaller hormone load. Second, only the SubQ formulation is designed and labeled for self-administration; the intramuscular injection is not considered safe to self-inject at home. Third, the SubQ version became the basis for self-administration policy when the CDC endorsed self-administered subcutaneous DMPA in 2021, with an updated Selected Practice Recommendations for Contraceptive Use following in 2024.

Depo-SubQ Provera 104 is the only medroxyprogesterone acetate product formulated and labeled for home self-injection — the IM version is not.

For many patients, this shift is the point: a birth control method that no longer requires a clinic visit every three months. It is a substantial change in how contraception is delivered, but it places new responsibility on the person holding the syringe.

Storage and Preparation: Ensuring Medication Integrity at Home

Before you think about timing or technique, the medication has to be in usable condition. Depo-SubQ Provera 104 must be stored at room temperature, between 20°C and 25°C (68°F to 77°F), to maintain the right viscosity for injection. This is not a "store in the fridge and grab when ready" medication — refrigeration can change the thickness of the suspension and is not the labeled storage condition. If your home runs hot in summer or cold in winter, take a moment to think about where the box actually lives between doses.

Pre-injection checklist

Run through this list before each scheduled dose — it applies to the first injection and every one after:

• Confirm the syringe is sealed, the expiration date has not passed, and the liquid looks uniform (not separated, clumped, or discolored).
• Check that the medication has been stored at room temperature (20°C to 25°C / 68°F to 77°F) for the period since you received it.
• Confirm you are within the correct window from your last injection — typically 12 to 14 weeks, with 13 weeks as the standard target.
• Have a clean work surface, the prefilled syringe, an alcohol swab, and a sharps disposal container ready.
• Wash your hands thoroughly with soap and water.
• Choose your injection site: the anterior thigh or the abdomen (avoiding the area right around the navel).
• Decide whether a backup non-hormonal method (such as condoms) is needed based on your cycle timing — see the next section.

If any item on this list is off — expired, out of range, separated liquid, missed the timing window — pause and contact your prescriber before injecting.

Timing and Back-up Contraception: Managing Your 13-Week Schedule

Depo-SubQ Provera 104 is effective when injected once every 12 to 14 weeks, with the standard schedule set at roughly 13 weeks (three months). The window is forgiving in length but not in calendar slippage: a dose given late leaves an opening for ovulation, and pregnancy can occur during that gap.

The rules around when you start your first dose determine whether you need backup contraception:

• If your first injection is given within the first 5 to 7 days of a normal menstrual period, no backup method is required.
• If your first injection falls more than 5 to 7 days after the start of your period, use a non-hormonal backup method (such as condoms) for 7 days after the injection.
• For ongoing doses, the goal is to stay inside the 12 to 14-week window. If you cannot make a scheduled appointment on time, contact your prescriber in advance to plan around it rather than letting the date pass unmarked.

The 13-week schedule is forgiving in length but not in slippage — a late dose is the most common way Depo coverage fails.

A practical habit is to mark the next-dose date on a calendar before you finish your current injection, and set a reminder a week ahead. Patients who travel, switch time zones, or have unpredictable schedules often plan the date around a known anchor — a recurring appointment, a paycheck, a monthly bill — rather than counting forward from the last dose in their head.

Step-by-Step Injection Technique: The 45-Degree Approach

The SubQ injection is short, slow, and specific in its geometry. There is no aspirating, no intramuscular reach, and no clinic-grade speed — the entire motion is built around the space just under the skin.

Injection sequence

1. Clean the chosen site on the anterior thigh or abdomen with an alcohol swab and let it air-dry.

2. Pinch a fold of skin at the site, lifting the subcutaneous tissue away from the muscle underneath.

3. Hold the syringe at a 45-degree angle to the pinched skin — this is the labeled approach for subcutaneous delivery.

4. Insert the needle with a smooth, controlled motion.

5. Depress the plunger slowly, over 5 to 7 seconds, until the full dose is delivered.

6. Withdraw the needle at the same 45-degree angle.

7. Release the pinched skin.

8. Do not rub or massage the injection site afterward — rubbing can alter drug absorption.

9. Dispose of the entire used syringe in a sharps container immediately.

A few details worth noting. The 45-degree angle is not decorative; it is what positions the medication in the subcutaneous layer where it is designed to be absorbed. The 5-to-7-second slow push is similarly specific — fast delivery into this tissue can cause stinging or bruising. And the "no rubbing" rule is one that patients sometimes ignore because it feels natural to press on a sore spot; the FDA labeling is explicit on this point.

If you have never self-injected before, ask your prescriber whether a training demonstration is available in your area. The facturage for this guide does not confirm whether training is legally required in every jurisdiction, so the safest assumption is that it is available on request rather than guaranteed automatically.

Long-Term Considerations: Bone Mineral Density and Usage Limits

Depo-Provera has carried an FDA boxed warning about bone mineral density (BMD) loss since the early 2000s, and that warning applies to the SubQ formulation as well. The label recommends that long-term use beyond 2 years is not advised unless other contraceptive options are inadequate. This is not a minor caveat — it is the most significant long-term medical consideration attached to the method, and the reason prescribers usually want to revisit your contraceptive plan around the two-year mark.

What this means practically:

• The bone density loss associated with Depo-Provera use is a documented, labeled risk. Whether it reverses fully depends on individual factors, and patients should not assume complete recovery in every case.
• Calcium and vitamin D intake, weight-bearing exercise, and lifestyle factors that support bone health are worth discussing with your prescriber — not as an alternative to reconsidering the method, but as a complement.
• Around the two-year mark, your prescriber is likely to ask whether Depo is still the best fit, or whether a different method (a progestin-only pill, an IUD, a barrier method, fertility awareness with a backup plan) would serve you better with less skeletal risk.
• Smokers, patients with a family history of osteoporosis, and those with low body weight may need a shorter reassessment cycle.

The FDA boxed warning on Depo-Provera recommends reassessment at 2 years — this is not a routine footnote, it is the labeled limit of continuous use absent other options.

The boxed warning is also why this method is often framed as a medium-term solution rather than a lifelong one. For patients who need long-acting contraception across a decade or more, an IUD or implant typically carries a more favorable bone density profile — though the choice between methods is always individual.

Final Thought: A Method That Rewards the Prep

Self-administered Depo-SubQ Provera 104 puts a clinician-grade contraceptive in a prefilled syringe in your bathroom drawer. The tradeoff is that the parts of the process a clinic used to handle — confirming medication integrity, scheduling the next dose, watching the calendar, deciding whether backup contraception is needed — now live with you. The checklist above is built around those handoffs: storage at room temperature, the 12-to-14-week window, the 45-degree angle, the 5-to-7-second push, the 2-year reassessment. Each one is small on its own; together they are how the method works as designed.

The point of the prep is not perfection. It is that, on the day your next dose is due, you are not improvising — you are following a rhythm you set for yourself three months ago.